ECG monitoring equipment market to reach $1.25 billion by 2017

The global ECG telemetry devices market is expected to reach some $1.25 billion by 2017, according to a report published by Global Industry Analysts (GIA). 

The report indicates that the market for ECG monitoring equipment continues to expand steadily. GIA's analysts attributed the rise to aging world population and increasing incidence of cardiovascular diseases. The added that, technology innovations are expected to boost the sales of telemetry systems.

"With most hospitals moving towards computerization for maintaining Electrocardiogram (ECG) records, investment in data management systems continue to account for a major share of hospital budgets," The authors noted. 

"Rising expenditure and scarcity of alternative home care resources and services are further expected to add to the growing demand for home telemetry monitoring devices. With growing number of people receiving home care, there exists strong potential for growth in the home care monitoring devices and telemetry devices segments."

The report names Aerotel Medical Systems as one of the major players in this field. Aerotel ECG telemetry devices include:

• Wireless ECG – Aerotel’s HeartView Personal hand-held 12-lead ECG monitor with Bluetooth connectivity. The solution enables easy and effective transmission of clinical information to a remote monitoring center for interpretation and immediate care. 
  
  
• Mobile-CliniQ – a mobile phone application that enables remote monitoring of various health parameters such as electrocardiogram (ECG), blood pressure, blood glucose level, weight, etc. 
  
  
• Heartline ECG Monitoring – Aerotel's Heartline is designed for various diagnostic, emergency and monitoring service applications. It comprises a complete range of personal, 1 to 12 lead transtelephonic or digital ECG devices for various remote diagnostic and emergency service applications. 

HeartView P12/8 Personal12-Lead ECG

The report indicates that while the US represents the largest regional market for ECG telemetry devices, Asia-Pacific represents the fastest growing region, creating significant opportunities.

Aerotel's mHealth solutions draw interest at MWC 2012

Aerotel Medical System's mobile health (mHealth) and telemedicine solutions draw much interest at the Mobile World Congress (MWC) 2012, held earlier this month in Barcelona, Spain.

"Visitors showed much interest in our mHealth products," said Ofer Atzmon, Aerotel's VP Business Development and Marketing. "Senior executives from telecom companies, consultancy companies and healthcare providers came to meet Aerotel's management at our booth at the Israeli National Pavilion."

Aerotel booth at MWC 2012

Special interest was paid to Aerotel's innovative location-based personal alert system, GeoSkeeper, which recently received the U.S. Federal Communications Commission (FCC) Certification as well as Industry Canada (IC) certification.

Research indicates that the cost of managing chronic diseases is the largest portion of health care expenditures in developed countries. With rising aging populations, governments and healthcare providers are constantly looking for ways to lower expanses. Telemedicine solutions, such as those provided by Aerotel, could generate significant cost savings.

A recent report published by the GSMA and accounting firm PwC indicates that the worldwide mHealth revenue is expected to reach about $23 billion by 2017.

Source: GSMA and PwC report

The largest markets for mobile health services are expected to be Europe and Asia-Pacific (30 percent market share each), North America (28%), Latin America (7%) and Africa (5%)

Among the various categories, monitoring services, such as Aerotel's Connect-Cell, will account for the largest share (65%), corresponding to about US$ 15 billion in 2017.

Due to the growing interest in mHealth in the telecom sector, Aerotel will participate this year for the first time at the CTIA Wireless show in the US, and many high-level meetings with service providers are already scheduled.